Pharmaceutical Industry Blog

Last Updated: June 30, 2026 TL;DR: Diclofenac Potassium Injection - a sterile aqueous solution of diclofenac potassium, a potent phenylacetic-acid (arylacetic-acid) NSAID and non-selective inhibitor of cyclo-oxygenase, supplied commonly as a 25 mg/mL solution in a 3 mL ampoule (75 mg/3 mL) given by deep intramuscular injection or, after dilution, by intravenous infusion - is the rapid-onset, non-opioid analgesic clinicians use for the short-term management of acute pain such

Last Updated: June 30, 2026 TL;DR: Piroxicam Injection - a sterile aqueous solution of piroxicam, a potent oxicam (enolic-acid) NSAID and non-selective inhibitor of cyclo-oxygenase, supplied commonly as a 20 mg/mL solution in a 1 mL or 2 mL ampoule given by deep intramuscular injection - is the long-acting, non-opioid analgesic and anti-inflammatory clinicians use for the short-term management of acute musculoskeletal pain, acute gout and painful exacerbations of rheumatic di

Last Updated: June 29, 2026 TL;DR: Ketoprofen Injection - a sterile, clear aqueous solution of ketoprofen, a potent racemic propionic-acid (arylpropionic) NSAID and non-selective inhibitor of cyclo-oxygenase, supplied commonly as a 100 mg/2 mL ampoule (50 mg/mL) given by deep intramuscular injection or, after dilution, by intravenous infusion - is the strong, non-opioid analgesic and anti-inflammatory clinicians use for the short-term management of acute pain and inflammation

Last Updated: June 29, 2026 TL;DR: Dexketoprofen Injection - a sterile, clear, colourless aqueous solution of dexketoprofen (as the trometamol salt), the active S(+)-enantiomer of ketoprofen and a potent propionic-acid (arylpropionic) NSAID, supplied commonly as a 50 mg/2 mL ampoule (25 mg/mL) given by intramuscular or slow intravenous injection - is the fast-acting, non-opioid analgesic clinicians use for the short-term management of acute moderate-to-severe pain such as pos

Last Updated: June 28, 2026 TL;DR: Meloxicam Injection - a sterile, clear yellow aqueous solution of meloxicam, an enolic-acid oxicam NSAID with preferential COX-2 activity, solubilised with meglumine and supplied commonly as a 15 mg/1.5 mL ampoule (10 mg/mL) given by deep intramuscular injection - is the once-daily, strong non-opioid anti-inflammatory clinicians use for the short-term symptomatic treatment of painful exacerbations of osteoarthritis, rheumatoid arthritis and

Last Updated: June 28, 2026 TL;DR: Etoricoxib Injection - a sterile, ready-to-use aqueous solution of etoricoxib, one of the most COX-2 selective of the coxib NSAIDs, supplied commonly as a 60 mg/2 mL ampoule (30 mg/mL) given by deep intramuscular injection - is the strong, non-opioid analgesic and anti-inflammatory clinicians use for the short-term control of acute pain and the painful flares of osteoarthritis, rheumatoid arthritis, ankylosing spondylitis and acute gout, whe